In many tumors such as lung, prostate, bladder, breast, and colon cancers, ACLY is pathologically overexpressed or has enhanced enzymatic activity (Khwairakpam et al., 2015; Granchi, 2018; Icard et al., 2020). The gene discussed is ACLY; the disease is malignant colon neoplasm.